HCV protease inhibitor Merimepodib, Purity ≥98%

Synonym: 198821-22-6; HCV protease inhibitor; VI-21497; VI21497; VI 21497; VX-497; VX497; VX 497; MMP

MDL: MFCD09837807
CAS Number: 198821-22-6
Compound CID: 153241

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

Merimepodib, soluble in DMSO and insoluble in ethanol and water, targets and inhibits the protease enzyme of the Hepatitis C virus, thereby preventing viral replication.

Molecular Weight

452.46

Molecular Formula

C₂₃H₂₄N₄O₆

Form

Lyophilized powder

Purity

Solubility

DMSO: 89 mg/mL (196.7 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

Merimepodib is an HCV protease inhibitor researched for its effectiveness in inhibiting the Hepatitis C virus.